Medicare Extends Coverage to Off Label Drugs

Medicare has widened its cancer coverage to include treatments not approved by the FDA.  With this shift, cancer patients can benefit from the most current therapies.  Opponents argue that they will also...

closeSign in to NowPublic

is reporting from